Kohei Otsubo

Effects of organic anion transporting polypeptide 1B1 haplotype on pharmacokinetics of pravastatin, valsartan, and temocapril

Kiyoshi Maeda, Ichiro Ieiri, Kiyomi Yasuda et al. · Clinical Pharmacology & Therapeutics · 2006 · 199 citations

PD-L1 expression in lung adenocarcinoma harboring EGFR mutations or ALK rearrangements

Yasuto Yoneshima, Kayo Ijichi, Satoshi Anai et al. · Lung Cancer · 2018 · 97 citations

Pd-l1 Expression, Medicine, Lung Adenocarcinoma +9

Clinical impact of probiotics on the efficacy of <scp>anti‐PD</scp>‐1 monotherapy in patients with nonsmall cell lung cancer: A multicenter retrospective survival analysis study with inverse probability of treatment weighting

Kazuki Takada, Mototsugu Shimokawa, Shinkichi Takamori et al. · International Journal of Cancer · 2021 · 85 citations · Full text

Probiotic, Treatment Weighting, Cell Lung Cancer +13

Safety and efficacy of PD-1 inhibitors in non–small cell lung cancer patients positive for antinuclear antibodies

Yasuto Yoneshima, Kentaro Tanaka, Yoshimasa Shiraishi et al. · Lung Cancer · 2019 · 82 citations

Oncology, Medicine, Immunology +11

Nintedanib plus chemotherapy for nonsmall cell lung cancer with idiopathic pulmonary fibrosis: a randomised phase 3 trial

Kohei Otsubo, Junji Kishimoto, Masahiko Ando et al. · European Respiratory Journal · 2022 · 81 citations